advertising
-
1
Lazarus GS, Cooper DM, Knighton DR, et al: Definitions and guidelines for assessment of wounds and evaluation of healing. .Arch Dermatol 130::489. ,1994. .
-
2
The Wound Product Sourcebook 2001, 3rd Ed, Kestrel Health Information, Williston, VT, 2001..
-
3
2000 Ostomy Wound Management Buyers Guide. .Ostomy Wound Manage 46::5. ,2001. .
-
4
Mulder GD, Haberor PA, Jeter KF (eds): Clinician’s Pocket Guide to Chronic Wound Repair. Wound Care Communications Network, Springhouse Corp, Springhouse, PA, 1998..
-
5
Thomas S: Update: a guide to dressing selection. .J Wound Care 6::479. ,1997. .
-
6
Steed DL: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers: Diabetic Ulcer Study Group. .J Vasc Surg 21::71. ,1995. .
-
7
Sihl N: Diabetes and wound healing. .J Wound Care 7::47. ,1998. .
-
8
Pecoraro R, Ahroni JH, Boyko EJ, et al: Chronology and determination of tissue repair in diabetic lower-extremity ulcers. .Diabetes 40::1305. ,1991. .
-
9
Robson MC, Hill DP, Smith PD, et al: Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response. .Ann Surg 231::600. ,2000. .
-
10
Bello Y, Phillips TJ: Predictors of wound healing. .J Clin Dermatol 2::39. ,1999. .
-
11
Vande Berg JS, Rudolph R, Hollan C, et al: Fibroblast senescence in pressure ulcers. .Wound Repair Regen 6::38. ,1998. .
-
12
Mendez MV, Raffetto JD, Phillips T, et al: The proliferative capacity of neonatal skin fibroblasts is reduced after exposure to venous ulcer wound fluid: a potential mechanism for senescence in venous ulcers. .J Vasc Surg 30::734. ,1999. .
-
13
Vande Berg JS, Smith PD, Munson AB, et al: Influence of single and sequential cytokine therapy on the cell cycle of pressure ulcer fibroblasts. Wound Rep Regen, in press..
-
14
Vande Berg JS, Smith PD, Haywood-Reid PL, et al: Dynamic forces in the cell cycle affecting fibroblasts in pressure ulcers. .Wound Repair Regen 9::19. ,2001. .
-
15
Nwomeh BC, Liang HX, Diegelmann RF, et al: MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. .J Surg Res 81::189. ,1999. .
-
16
Nwomeh BC, Liang HX, Diegelmann RF, et al: Dynamics of matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds. .Wound Repair Regen 6::127. ,1998. .
-
17
Woessner JF, Jr: The family of matrix metalloproteinases. .Ann N Y Acad Sci 732::11. ,1994. .
-
18
Agren MS: Gelatinase activity during wound healing. .Br J Dermatol 131::634. ,1994. .
-
19
Tarnuzzer RW, Schultz GS: Biochemical analysis of acute and chronic wound environments. .Wound Rep Regen 4::321. ,1996. .
-
20
Mast BA, Schultz GS: Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. .Wound Rep Regen 4::411. ,1996. .
Cellular Senescence and Matrix Metalloproteinase Activity in Chronic Wounds
Relevance to Debridement and New Technologies
Search for other papers by Gerit D. Mulder in
Current site
Google Scholar
PubMed
Search for other papers by Jerry S. Vande Berg in
Current site
Google Scholar
PubMed
A prolonged inflammatory response may adversely affect wound closure. Delayed wound closure and extended exposure to chronic wound fluid may also affect cellular activity in a wound bed and result in cellular senescence. Prolonged inflammation and cellular senescence may adversely affect the efficacy of topically-applied biological agents, including growth factors. Appropriate wound bed preparation and debridement are necessary to improve clinical outcomes of new technologies.(J Am Podiatr Med Assoc 92(1): 34-37, 2002)
advertising
